How much funding has Guardant Health raised?

Guardant Health has raised $540.0M in total funding, most recently a Series E round.

Who are Guardant Health's investors?

Guardant Health's investors include Sequoia Capital, SoftBank, Lightspeed VP, Khosla Ventures.

When was Guardant Health founded?

Guardant Health was founded in 2012.

Where is Guardant Health headquartered?

Guardant Health is headquartered in Palo Alto, California, United States.

What industry is Guardant Health in?

Guardant Health operates in Biotech, Healthcare.

How many employees does Guardant Health have?

Guardant Health has 1001-5000 employees.

Guardant Health

IPO

Conquering Cancer With Data

Public · Palo Alto, United States · Founded 2012 · $540.0M raised

Biotech

Healthcare

Headquarters: Palo Alto, California
Employees: 1001–5000
Founded: 2012
Business Model: B2B
Website: guardanthealth.com

Total Funding: $540.0M
Last Round: $360.0M Series EMay 2017
Rounds: 4
Type: Public

About

Guardant Health is a leading precision oncology company that uses liquid biopsy technology to transform cancer care. Its blood tests—including the Shield screening test and Guardant360 oncology portfolio—enable early cancer detection and guide treatment decisions for over 12,000 physicians. The company combines advanced genomics with real-world data and AI analytics to accelerate drug development for biopharma partners.

Summary

Guardant Health is a Biotech company based in Palo Alto, United States, founded in 2012. It has raised $540.0M in total across 4 rounds, most recently a $360.0M Series E round in May 2017. Investors include Sequoia Capital, SoftBank and Lightspeed VP.

LinkedIn X (Twitter)